Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

PubMed Links for Books (Select 1508776)

1.

Human dosimetry and preliminary tumor distribution of 18F-fluoropaclitaxel in healthy volunteers and newly diagnosed breast cancer patients using PET/CT.

Kurdziel KA, Kalen JD, Hirsch JI, Wilson JD, Bear HD, Logan J, McCumisky J, Moorman-Sykes K, Adler S, Choyke PL.

J Nucl Med. 2011 Sep;52(9):1339-45. doi: 10.2967/jnumed.111.091587. Epub 2011 Aug 17.

2.

Estimation of paclitaxel biodistribution and uptake in human-derived xenografts in vivo with (18)F-fluoropaclitaxel.

Gangloff A, Hsueh WA, Kesner AL, Kiesewetter DO, Pio BS, Pegram MD, Beryt M, Townsend A, Czernin J, Phelps ME, Silverman DH.

J Nucl Med. 2005 Nov;46(11):1866-71.

3.

Biodistribution, radiation dose estimates, and in vivo Pgp modulation studies of 18F-paclitaxel in nonhuman primates.

Kurdziel KA, Kiesewetter DO, Carson RE, Eckelman WC, Herscovitch P.

J Nucl Med. 2003 Aug;44(8):1330-9.

4.

Fluoro-, bromo-, and iodopaclitaxel derivatives: synthesis and biological evaluation.

Kiesewetter DO, Jagoda EM, Kao CH, Ma Y, Ravasi L, Shimoji K, Szajek LP, Eckelman WC.

Nucl Med Biol. 2003 Jan;30(1):11-24.

PMID:
12493538
5.

Modulation of doxorubicin concentration by cyclosporin A in brain and testicular barrier tissues expressing P-glycoprotein in rats.

Hughes CS, Vaden SL, Manaugh CA, Price GS, Hudson LC.

J Neurooncol. 1998 Mar;37(1):45-54.

PMID:
9525837
6.

Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833.

Mayer U, Wagenaar E, Dorobek B, Beijnen JH, Borst P, Schinkel AH.

J Clin Invest. 1997 Nov 15;100(10):2430-6.

7.

Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells.

Huang Y, Ibrado AM, Reed JC, Bullock G, Ray S, Tang C, Bhalla K.

Leukemia. 1997 Feb;11(2):253-7.

PMID:
9009089
8.

Biochemistry of multidrug resistance mediated by the multidrug transporter.

Gottesman MM, Pastan I.

Annu Rev Biochem. 1993;62:385-427. Review. No abstract available.

PMID:
8102521
9.

Taxol: mechanisms of action and resistance.

Horwitz SB, Cohen D, Rao S, Ringel I, Shen HJ, Yang CP.

J Natl Cancer Inst Monogr. 1993;(15):55-61. Review.

PMID:
7912530
10.

Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation.

Piwnica-Worms D, Rao VV, Kronauge JF, Croop JM.

Biochemistry. 1995 Sep 26;34(38):12210-20.

PMID:
7547962
11.

The biochemistry of P-glycoprotein-mediated multidrug resistance.

Endicott JA, Ling V.

Annu Rev Biochem. 1989;58:137-71. Review. No abstract available.

PMID:
2570548
12.

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.

Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC.

Proc Natl Acad Sci U S A. 1987 Nov;84(21):7735-8.

13.

Expression of a multidrug-resistance gene in human tumors and tissues.

Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I.

Proc Natl Acad Sci U S A. 1987 Jan;84(1):265-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk